Langerhans cell histiocytosis presenting as a rapidly evolving frontotemporal syndrome

被引:6
作者
Garg, Divyani [1 ]
Pedapati, Radhakrishna [1 ]
Nakra, Tripti [2 ]
Singh, Rajesh Kumar [1 ]
Prabhakar, Anuj [3 ]
Dash, Deepa [1 ]
Bhatia, Rohit [1 ]
Tripathi, Manjari [1 ]
机构
[1] All India Inst Med Sci, Dept Neurol, New Delhi, India
[2] All India Inst Med Sci, Dept Neuropathol, New Delhi, India
[3] All India Inst Med Sci, Dept Neuroradiol, New Delhi, India
关键词
Langerhans cell histiocytosis; Hypothalamus; Cognition; Dementia;
D O I
10.1007/s10072-019-3709-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Langerhans cell histiocytosis (LCH) is a rare disorder in adults which usually manifests with involvement of multiple organ systems, including the central nervous system. We describe an unusual case of biopsy-proven LCH presenting with frontotemporal-dominant cognitive impairment with hypothalamic involvement, along with multisystem disease. We propose that the dementia was probably an immune-mediated process triggered by LCH which responded dramatically to high-dose steroids.
引用
收藏
页码:1055 / 1058
页数:4
相关论文
共 11 条
  • [1] Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans Cells
    Allen, Carl E.
    Li, Liunan
    Peters, Tricia L.
    Leung, Hon-Chiu Eastwood
    Yu, Alexander
    Man, Tsz-Kwong
    Gurusiddappa, Sivashankarappa
    Phillips, Michelle T.
    Hicks, M. John
    Gaikwad, Amos
    Merad, Miriam
    McClain, Kenneth L.
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 184 (08) : 4557 - 4567
  • [2] Neurodegenerative Central Nervous System Langerhans Cell Histiocytosis and Coincident Hydrocephalus Treated With Vincristine/Cytosine Arabinoside
    Allen, Carl E.
    Flores, Ricardo
    Rauch, Ronald
    Dauser, Robert
    Murray, Jeffrey C.
    Puccetti, Diane
    Hsu, David A.
    Sondel, Paul
    Hetherington, Maxine
    Goldman, Stan
    McClain, Kenneth L.
    [J]. PEDIATRIC BLOOD & CANCER, 2010, 54 (03) : 416 - 423
  • [3] Baumgartner I, 1997, MED PEDIATR ONCOL, V28, P9, DOI 10.1002/(SICI)1096-911X(199701)28:1<9::AID-MPO3>3.0.CO
  • [4] 2-P
  • [5] Emile JF, 2016, BLOOD, V127, P2672, DOI [10.1182/blood-2016-01690636, 10.1182/blood-2016-01-690636]
  • [6] Endocrine manifestations of Langerhans cell histiocytosis diagnosed in adults
    Garcia Gallo, M. S.
    Martinez, M. P.
    Abalovich, M. S.
    Gutierrez, S.
    Guitelman, M. A.
    [J]. PITUITARY, 2010, 13 (04) : 298 - 303
  • [7] Langerhans Cell Histiocytosis
    Grana, Nanette
    [J]. CANCER CONTROL, 2014, 21 (04) : 328 - 334
  • [8] Risk factors for diabetes insipidus in langerhans cell histiocytosis
    Grois, N
    Pötschger, U
    Prosch, H
    Minkov, M
    Arico, M
    Braier, J
    Henter, JI
    Janka-Schaub, G
    Ladisch, S
    Ritter, J
    Steiner, M
    Unger, E
    Gadner, H
    [J]. PEDIATRIC BLOOD & CANCER, 2006, 46 (02) : 228 - 233
  • [9] Neuropathology of CNS disease in Langerhans cell histiocytosis
    Grois, N
    Prayer, D
    Prosch, H
    Lassmann, H
    [J]. BRAIN, 2005, 128 : 829 - 838
  • [10] Tamai Sho, 2018, Surg Neurol Int, V9, P197, DOI 10.4103/sni.sni_229_18